Cerebral cavernous hemangiomas at 7 Tesla: initial experience

Acad Radiol. 2010 Jan;17(1):3-6. doi: 10.1016/j.acra.2009.10.001. Epub 2009 Nov 12.

Abstract

Rationale and objectives: Cavernous malformations (cavernomas) occur in 0.4%-0.9% of the population. The most common symptoms of cavernous malformations are seizures. An improved detection of small cavernomas might possibly help to clarify cryptogenic seizures, which represent 30% of all seizures. The aim of this study was to evaluate the benefit of magnetic resonance imaging at a field strength of 7 T in the detection of cavernomas.

Materials and methods: Ten consecutive patients with known cavernomas were enrolled in this study. First a T2*-weighted gradient echo sequence was performed at 1.5 T with a slice thickness of 6 mm in axial orientation. Subsequently, the examination was repeated at 7 T. Both examinations were independently read by two blinded senior neuroradiologists. Localization and dimension of the hypointensities were recorded.

Results: One additional hypointensity was detected in one patient, which was not visible in the 1.5 T examination even retrospectively. In another patient with known cavernomatosis, innumerable new small hypointense lesions were detected at 7 T.

Conclusion: Our small series suggests that ultra-high-field magnetic resonance imaging at 7 T improves the detection of cavernomas.

MeSH terms

  • Adult
  • Brain / pathology*
  • Brain Neoplasms / pathology*
  • Female
  • Hemangioma, Cavernous, Central Nervous System / pathology*
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Pilot Projects
  • Reproducibility of Results
  • Sensitivity and Specificity